Discovery Capital Management, LLC Alaunos Therapeutics, Inc. Transaction History

Discovery Capital Management, LLC

$732 Million
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$0.04 - $0.13 $458,398 - $1.49 Million	-11,459,973 Reduced 74.12%	4,001,856 $280,000
Q3 2023 Nov 14, 2023	SELL	$0.12 - $0.5 $21,743 - $90,597	-181,194 Reduced 1.16%	15,461,829 $2.01 Million
Q1 2023 May 15, 2023	SELL	$0.46 - $0.81 $249,768 - $439,809	-542,975 Reduced 3.35%	15,643,023 $9.86 Million
Q4 2022 Feb 14, 2023	BUY	$0.5 - $261.0 $771,519 - $403 Million	1,543,039 Added 10.54%	16,185,998 $10.5 Million
Q3 2022 Nov 14, 2022	BUY	$1.04 - $322.5 $538,595 - $167 Million	517,880 Added 3.67%	14,642,959 $25.2 Million
Q2 2022 Aug 15, 2022	BUY	$0.41 - $1.24 $45,914 - $138,862	111,986 Added 0.8%	14,125,079 $17.5 Million
Q1 2022 May 16, 2022	BUY	$0.62 - $1.17 $413,292 - $779,922	666,600 Added 4.99%	14,013,093 $9.14 Million
Q4 2021 Feb 14, 2022	BUY	$1.09 - $1.89 $872,000 - $1.51 Million	800,000 Added 6.38%	13,346,493 $14.5 Million
Q3 2021 Nov 15, 2021	BUY	$1.44 - $2.73 $85,343 - $161,796	59,266 Added 0.47%	12,546,493 $22.8 Million
Q2 2021 Aug 16, 2021	BUY	$2.63 - $3.67 $1.15 Million - $1.6 Million	437,220 Added 3.63%	12,487,227 $33 Million
Q1 2021 May 17, 2021	BUY	$2.82 - $5.6 $163,514 - $324,710	57,984 Added 0.48%	12,050,007 $43.4 Million
Q4 2020 Feb 16, 2021	BUY	$2.09 - $3.09 $3.31 Million - $4.9 Million	1,585,173 Added 15.23%	11,992,023 $30.2 Million
Q3 2020 Nov 16, 2020	BUY	$2.39 - $3.43 $1.83 Million - $2.62 Million	764,090 Added 7.92%	10,406,850 $26.2 Million
Q2 2020 Aug 14, 2020	BUY	$2.2 - $3.71 $220,000 - $371,000	100,000 Added 1.05%	9,642,760 $31.6 Million
Q1 2020 May 15, 2020	BUY	$1.9 - $4.98 $9.21 Million - $24.1 Million	4,846,014 Added 103.18%	9,542,760 $23.4 Million
Q4 2019 Feb 14, 2020	BUY	$3.95 - $5.35 $2 Million - $2.71 Million	505,619 Added 12.06%	4,696,746 $22.2 Million
Q3 2019 Nov 14, 2019	BUY	$4.13 - $6.94 $5.95 Million - $9.99 Million	1,439,739 Added 52.33%	4,191,127 $17.9 Million
Q2 2019 Aug 14, 2019	BUY	$3.98 - $6.2 $3.96 Million - $6.17 Million	994,575 Added 56.61%	2,751,388 $16 Million
Q1 2019 May 15, 2019	BUY	$2.0 - $4.4 $3.51 Million - $7.73 Million	1,756,813 New	1,756,813 $6.76 Million

Others Institutions Holding TCRT

# of Institutions

Shares Held

92.6K

Call Options Held

Put Options Held

View Full List

About Alaunos Therapeutics, Inc.

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $517M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

More about TCRT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Discovery Capital Management, LLC , based on Form 13F filings with the SEC.

News

Stay updated on Discovery Capital Management, LLC with notifications on news.

Account